BDKANN - Biological Domain Knowledge-based Artificial Neural Network for drug response prediction
Snow, O.; Sharifi, H.; Lu, J.; Zolotareva, O.; Lee, M.; Ester, M.
Show abstract
MotivationOne of the main goals of precision oncology is to predict the response of a patient to a given cancer treatment based on their genomic profile. Although current models for drug response prediction are becoming more accurate, they are also black boxes and cannot explain their predictions, which is of particular importance in cancer treatment. Many models also do not leverage prior biological knowledge, such as the hierarchical information on how proteins form complexes and act together in pathways. ResultsIn this work, we use this prior biological knowledge to form the architecture of a deep neural network to predict cancer drug response from cell line gene expression data. We find that our approach not only has a low prediction error compared to baseline models but also allows meaningful interpretation of the network. These interpretations can both explain predictions made and discover novel connections in the biological knowledge that may lead to new hypotheses about mechanisms of drug action. AvailabilityCode at https://github.com/osnow/BDKANN Supplementary informationIncluded with submission
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Graph-Attention-Based Deep Learning Network for Predicting Biotech-Small-Molecule Drug Interactions 96%
- Mining drug-target interactions from biomedical literature using chemical and gene descriptions-based ensemble transformer model. 96%
- FLONE: fully Lorentz network embedding for inferring novel drug targets 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.